This inventor holds 1 USPTO granted patent. Top assignees: The City University of New York, The Rockefeller University. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 336 
1 out of 751 
Years Active: 2017
Title: Mande Holford: Innovator in Cancer Treatment
Introduction
Mande Holford is a distinguished inventor based in New York, NY, known for his groundbreaking work in cancer treatment. He has made significant contributions to the field of medical science, particularly through his innovative approach to treating liver cancer.
Latest Patents
Holford holds a patent for a method of treating liver cancer using a peptide derived from the venom of the terebrid snail, terebrid variegata. The patent describes a general formula of TRXCCGCYWNGSKDVCSQSCC (SEQ ID NO: 1) and includes variants of this peptide, showcasing his innovative approach to cancer therapy.
Career Highlights
Throughout his career, Mande Holford has been associated with prestigious institutions such as the City University of New York and The Rockefeller University. His work has not only advanced scientific understanding but has also opened new avenues for cancer treatment.
Collaborations
Holford has collaborated with notable colleagues, including Prachi Anand and Beatrix Ueberheide, who have contributed to his research endeavors.
Conclusion
Mande Holford's innovative work in cancer treatment exemplifies the potential of scientific research to address critical health challenges. His contributions continue to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile